Prevalence of cannabidiol (CBD) consumption and cancer patients’ expectations in one oncology day-hospital: A cross-sectional study and questionnaire validation

Prevalence of cannabidiol (CBD) consumption and cancer patients’ expectations in one oncology day-hospital: A cross-sectional study and questionnaire validation

Introduction The growing interest of cannabidiol (CBD) in medical care prompted French health authorities to explore the potential of CBD in cancer-related severe symptoms. This study aimed to assess the prevalence of CBD use among cancer patients with potential associated factors and to measure the...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of oncology pharmacy practice 2023-07, p.10781552231187136-10781552231187136
Hauptverfasser: Le Bozec, Antoine, Guédon, Marie, Brugel, Mathias, Laurent, Maeliss, Carlier, Claire, Hettler, Dominique, Perrier, Marine, Aubert, Léa, Slimano, Florian, Mongaret, Céline, Bouché, Olivier
Format: Artikel
Sprache:eng
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 10781552231187136
container_issue
container_start_page 10781552231187136
container_title Journal of oncology pharmacy practice
container_volume
creator Le Bozec, Antoine
Guédon, Marie
Brugel, Mathias
Laurent, Maeliss
Carlier, Claire
Hettler, Dominique
Perrier, Marine
Aubert, Léa
Slimano, Florian
Mongaret, Céline
Bouché, Olivier
description Introduction The growing interest of cannabidiol (CBD) in medical care prompted French health authorities to explore the potential of CBD in cancer-related severe symptoms. This study aimed to assess the prevalence of CBD use among cancer patients with potential associated factors and to measure the cancer patient's health literacy (HL) on CBD consumption. Methods In a prospective study in oncology day-care hospital including patients from 29 October to 20 December 2021, we collected demographic, biological, and oncological characteristics. Patient CBD HL was measured by the hetero-questionnaire 8-item-CBD HL scale (HLS-8-CBD) whose conception has been validated by a psychometric analysis. Results Among 363 participants, 20 patients (5.5%) reported CBD use. Factors associated with CBD use were: age
doi_str_mv 10.1177/10781552231187136
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2836878075</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sage_id>10.1177_10781552231187136</sage_id><sourcerecordid>2836878075</sourcerecordid><originalsourceid>FETCH-LOGICAL-c335t-af8e8661e3618ddea744a8377ef69eeac4747cda635d56eeb3e14323cae9117a3</originalsourceid><addsrcrecordid>eNp9kbtu2zAUhokiRe24fYAuAcd0kCuKkkhnc5wrECAdWqCbcEweOQxkUiGlIt7yGlnzaH2SULbbJUAmEuT3fzgXQr6ydMqYEN9ZKiQriizjjEnBePmBjFkuRJLOst8H8R7_kwEYkcMQ7tM0lSKTn8iIi5wLJrMxefnh8Q80aBVSV1MF1sLSaOMaerw4PftGlbOhX7edcZaC1QOh0NMWOoO2C3-fnik-tqg6GJBAjaXORpdVrnGrDdWwSe5caE0HzQmdU-VdCEmIgYhDQ0PX683W_NBjGB4tGI80FmX01vmZfKyhCfhlf07Ir4vzn4ur5Ob28noxv0kU50WXQC1RliVDXjKpNYLIc5BcCKzLGSKoXORCaSh5oYsSccmR5TzjCnAWpwl8Qo533ta7bS3V2gSFTQMWXR-qTPJSCpmKIqJsh2678VhXrTdr8JuKpdWwmurNamLmaK_vl2vU_xP_dhGB6Q4IsMLq3vU-zie8Y3wFNJibOg</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2836878075</pqid></control><display><type>article</type><title>Prevalence of cannabidiol (CBD) consumption and cancer patients’ expectations in one oncology day-hospital: A cross-sectional study and questionnaire validation</title><source>SAGE Complete A-Z List</source><creator>Le Bozec, Antoine ; Guédon, Marie ; Brugel, Mathias ; Laurent, Maeliss ; Carlier, Claire ; Hettler, Dominique ; Perrier, Marine ; Aubert, Léa ; Slimano, Florian ; Mongaret, Céline ; Bouché, Olivier</creator><creatorcontrib>Le Bozec, Antoine ; Guédon, Marie ; Brugel, Mathias ; Laurent, Maeliss ; Carlier, Claire ; Hettler, Dominique ; Perrier, Marine ; Aubert, Léa ; Slimano, Florian ; Mongaret, Céline ; Bouché, Olivier</creatorcontrib><description>Introduction The growing interest of cannabidiol (CBD) in medical care prompted French health authorities to explore the potential of CBD in cancer-related severe symptoms. This study aimed to assess the prevalence of CBD use among cancer patients with potential associated factors and to measure the cancer patient's health literacy (HL) on CBD consumption. Methods In a prospective study in oncology day-care hospital including patients from 29 October to 20 December 2021, we collected demographic, biological, and oncological characteristics. Patient CBD HL was measured by the hetero-questionnaire 8-item-CBD HL scale (HLS-8-CBD) whose conception has been validated by a psychometric analysis. Results Among 363 participants, 20 patients (5.5%) reported CBD use. Factors associated with CBD use were: age &lt;60 years (odd ratio = 7.80[1.36–13.32], p &lt; 10−4 versus ≥60 years), smoking history (OR = 5.53[1.81–16.88], p &lt; 0.01), and no smoking cessation (OR = 5.07[1.66–15.46], p &lt; 0.01). CBD use was also associated with a better CBD total HL score than non-users (p-value = 0.02). Conclusion Identification of factors associated with CBD use and a relatively high patient CBD HL in CBD users showed that CBD use in cancer patients care represented a new concern and should enhance health professionals to consider CBD with its associated drug-related problems.</description><identifier>ISSN: 1078-1552</identifier><identifier>EISSN: 1477-092X</identifier><identifier>DOI: 10.1177/10781552231187136</identifier><identifier>PMID: 37437182</identifier><language>eng</language><publisher>London, England: SAGE Publications</publisher><ispartof>Journal of oncology pharmacy practice, 2023-07, p.10781552231187136-10781552231187136</ispartof><rights>The Author(s) 2023</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c335t-af8e8661e3618ddea744a8377ef69eeac4747cda635d56eeb3e14323cae9117a3</cites><orcidid>0000-0002-0789-5180</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://journals.sagepub.com/doi/pdf/10.1177/10781552231187136$$EPDF$$P50$$Gsage$$H</linktopdf><linktohtml>$$Uhttps://journals.sagepub.com/doi/10.1177/10781552231187136$$EHTML$$P50$$Gsage$$H</linktohtml><link.rule.ids>314,777,781,21800,27905,27906,43602,43603</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/37437182$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Le Bozec, Antoine</creatorcontrib><creatorcontrib>Guédon, Marie</creatorcontrib><creatorcontrib>Brugel, Mathias</creatorcontrib><creatorcontrib>Laurent, Maeliss</creatorcontrib><creatorcontrib>Carlier, Claire</creatorcontrib><creatorcontrib>Hettler, Dominique</creatorcontrib><creatorcontrib>Perrier, Marine</creatorcontrib><creatorcontrib>Aubert, Léa</creatorcontrib><creatorcontrib>Slimano, Florian</creatorcontrib><creatorcontrib>Mongaret, Céline</creatorcontrib><creatorcontrib>Bouché, Olivier</creatorcontrib><title>Prevalence of cannabidiol (CBD) consumption and cancer patients’ expectations in one oncology day-hospital: A cross-sectional study and questionnaire validation</title><title>Journal of oncology pharmacy practice</title><addtitle>J Oncol Pharm Pract</addtitle><description>Introduction The growing interest of cannabidiol (CBD) in medical care prompted French health authorities to explore the potential of CBD in cancer-related severe symptoms. This study aimed to assess the prevalence of CBD use among cancer patients with potential associated factors and to measure the cancer patient's health literacy (HL) on CBD consumption. Methods In a prospective study in oncology day-care hospital including patients from 29 October to 20 December 2021, we collected demographic, biological, and oncological characteristics. Patient CBD HL was measured by the hetero-questionnaire 8-item-CBD HL scale (HLS-8-CBD) whose conception has been validated by a psychometric analysis. Results Among 363 participants, 20 patients (5.5%) reported CBD use. Factors associated with CBD use were: age &lt;60 years (odd ratio = 7.80[1.36–13.32], p &lt; 10−4 versus ≥60 years), smoking history (OR = 5.53[1.81–16.88], p &lt; 0.01), and no smoking cessation (OR = 5.07[1.66–15.46], p &lt; 0.01). CBD use was also associated with a better CBD total HL score than non-users (p-value = 0.02). Conclusion Identification of factors associated with CBD use and a relatively high patient CBD HL in CBD users showed that CBD use in cancer patients care represented a new concern and should enhance health professionals to consider CBD with its associated drug-related problems.</description><issn>1078-1552</issn><issn>1477-092X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2023</creationdate><recordtype>article</recordtype><recordid>eNp9kbtu2zAUhokiRe24fYAuAcd0kCuKkkhnc5wrECAdWqCbcEweOQxkUiGlIt7yGlnzaH2SULbbJUAmEuT3fzgXQr6ydMqYEN9ZKiQriizjjEnBePmBjFkuRJLOst8H8R7_kwEYkcMQ7tM0lSKTn8iIi5wLJrMxefnh8Q80aBVSV1MF1sLSaOMaerw4PftGlbOhX7edcZaC1QOh0NMWOoO2C3-fnik-tqg6GJBAjaXORpdVrnGrDdWwSe5caE0HzQmdU-VdCEmIgYhDQ0PX683W_NBjGB4tGI80FmX01vmZfKyhCfhlf07Ir4vzn4ur5Ob28noxv0kU50WXQC1RliVDXjKpNYLIc5BcCKzLGSKoXORCaSh5oYsSccmR5TzjCnAWpwl8Qo533ta7bS3V2gSFTQMWXR-qTPJSCpmKIqJsh2678VhXrTdr8JuKpdWwmurNamLmaK_vl2vU_xP_dhGB6Q4IsMLq3vU-zie8Y3wFNJibOg</recordid><startdate>20230712</startdate><enddate>20230712</enddate><creator>Le Bozec, Antoine</creator><creator>Guédon, Marie</creator><creator>Brugel, Mathias</creator><creator>Laurent, Maeliss</creator><creator>Carlier, Claire</creator><creator>Hettler, Dominique</creator><creator>Perrier, Marine</creator><creator>Aubert, Léa</creator><creator>Slimano, Florian</creator><creator>Mongaret, Céline</creator><creator>Bouché, Olivier</creator><general>SAGE Publications</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0002-0789-5180</orcidid></search><sort><creationdate>20230712</creationdate><title>Prevalence of cannabidiol (CBD) consumption and cancer patients’ expectations in one oncology day-hospital: A cross-sectional study and questionnaire validation</title><author>Le Bozec, Antoine ; Guédon, Marie ; Brugel, Mathias ; Laurent, Maeliss ; Carlier, Claire ; Hettler, Dominique ; Perrier, Marine ; Aubert, Léa ; Slimano, Florian ; Mongaret, Céline ; Bouché, Olivier</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c335t-af8e8661e3618ddea744a8377ef69eeac4747cda635d56eeb3e14323cae9117a3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2023</creationdate><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Le Bozec, Antoine</creatorcontrib><creatorcontrib>Guédon, Marie</creatorcontrib><creatorcontrib>Brugel, Mathias</creatorcontrib><creatorcontrib>Laurent, Maeliss</creatorcontrib><creatorcontrib>Carlier, Claire</creatorcontrib><creatorcontrib>Hettler, Dominique</creatorcontrib><creatorcontrib>Perrier, Marine</creatorcontrib><creatorcontrib>Aubert, Léa</creatorcontrib><creatorcontrib>Slimano, Florian</creatorcontrib><creatorcontrib>Mongaret, Céline</creatorcontrib><creatorcontrib>Bouché, Olivier</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Journal of oncology pharmacy practice</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Le Bozec, Antoine</au><au>Guédon, Marie</au><au>Brugel, Mathias</au><au>Laurent, Maeliss</au><au>Carlier, Claire</au><au>Hettler, Dominique</au><au>Perrier, Marine</au><au>Aubert, Léa</au><au>Slimano, Florian</au><au>Mongaret, Céline</au><au>Bouché, Olivier</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Prevalence of cannabidiol (CBD) consumption and cancer patients’ expectations in one oncology day-hospital: A cross-sectional study and questionnaire validation</atitle><jtitle>Journal of oncology pharmacy practice</jtitle><addtitle>J Oncol Pharm Pract</addtitle><date>2023-07-12</date><risdate>2023</risdate><spage>10781552231187136</spage><epage>10781552231187136</epage><pages>10781552231187136-10781552231187136</pages><issn>1078-1552</issn><eissn>1477-092X</eissn><abstract>Introduction The growing interest of cannabidiol (CBD) in medical care prompted French health authorities to explore the potential of CBD in cancer-related severe symptoms. This study aimed to assess the prevalence of CBD use among cancer patients with potential associated factors and to measure the cancer patient's health literacy (HL) on CBD consumption. Methods In a prospective study in oncology day-care hospital including patients from 29 October to 20 December 2021, we collected demographic, biological, and oncological characteristics. Patient CBD HL was measured by the hetero-questionnaire 8-item-CBD HL scale (HLS-8-CBD) whose conception has been validated by a psychometric analysis. Results Among 363 participants, 20 patients (5.5%) reported CBD use. Factors associated with CBD use were: age &lt;60 years (odd ratio = 7.80[1.36–13.32], p &lt; 10−4 versus ≥60 years), smoking history (OR = 5.53[1.81–16.88], p &lt; 0.01), and no smoking cessation (OR = 5.07[1.66–15.46], p &lt; 0.01). CBD use was also associated with a better CBD total HL score than non-users (p-value = 0.02). Conclusion Identification of factors associated with CBD use and a relatively high patient CBD HL in CBD users showed that CBD use in cancer patients care represented a new concern and should enhance health professionals to consider CBD with its associated drug-related problems.</abstract><cop>London, England</cop><pub>SAGE Publications</pub><pmid>37437182</pmid><doi>10.1177/10781552231187136</doi><orcidid>https://orcid.org/0000-0002-0789-5180</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1078-1552
ispartof Journal of oncology pharmacy practice, 2023-07, p.10781552231187136-10781552231187136
issn 1078-1552
1477-092X
language eng
recordid cdi_proquest_miscellaneous_2836878075
source SAGE Complete A-Z List
title Prevalence of cannabidiol (CBD) consumption and cancer patients’ expectations in one oncology day-hospital: A cross-sectional study and questionnaire validation
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-18T13%3A43%3A00IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Prevalence%20of%20cannabidiol%20(CBD)%20consumption%20and%20cancer%20patients%E2%80%99%20expectations%20in%20one%20oncology%20day-hospital:%20A%20cross-sectional%20study%20and%20questionnaire%20validation&rft.jtitle=Journal%20of%20oncology%20pharmacy%20practice&rft.au=Le%20Bozec,%20Antoine&rft.date=2023-07-12&rft.spage=10781552231187136&rft.epage=10781552231187136&rft.pages=10781552231187136-10781552231187136&rft.issn=1078-1552&rft.eissn=1477-092X&rft_id=info:doi/10.1177/10781552231187136&rft_dat=%3Cproquest_cross%3E2836878075%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2836878075&rft_id=info:pmid/37437182&rft_sage_id=10.1177_10781552231187136&rfr_iscdi=true